Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action
- PMID: 1900784
- DOI: 10.1210/endo-128-4-2036
Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action
Abstract
The GnRH antagonist antide is among the most promising "third generation" compounds available for clinical evaluation. In primates, antide manifests prolonged (several weeks) and reversible inhibition of pituitary gonadotropin secretion after a single high dose injection. In the present study, we have examined the effects of antide on pituitary gonadotropin secretion in vitro. Dispersed anterior pituitary cells from adult female rats were plated (48 h; 5 x 10(5) cells/well), washed, and exposed to increasing concentrations of antide for up to 48 h. Media were removed, and cells were washed twice and then incubated with GnRH (1 x 10(-8) M) plus antide for 4 h. Media and cell lysates were assayed for LH/FSH by RIA. Antide had no effect on basal LH/FSH secretion at any dose tested (10(-6)-10(-12) M). In contrast, GnRH-stimulated LH/FSH secretion was inhibited by this GnRH antagonist in a dose- and time-dependent manner. When incubated simultaneously, antide blocked GnRH-stimulated gonadotropin secretion, with a maximal effect at 10(-6) M (ED50, 10(-7) M). Preincubation of pituitary cells with antide for 6-48 h before GnRH exposure shifted the dose-response curve to the left; the maximally effective dose was 10(-8) M; the ED50 was 10(-10) M antide after 48-h preincubation. Intracellular LH/FSH levels increased concomitant with the decrease in secreted gonadotropins. Total LH/FSH levels (secreted plus cell content) remained unchanged. The inhibition of LH secretion by antide was specific for GnRH-stimulated gonadotropin secretion; antide had no effect on K(+)-stimulated LH secretion. Moreover, antide had little or no residual effect on LH secretion; full recovery of GnRH responsiveness in vitro occurred within 4 h after removal of antide. Lineweaver-Burke analysis of antide inhibition of GnRH-stimulated LH secretion indicated that antide is a direct competitor of GnRH at the level of the pituitary GnRH receptor. In summary, antide is a pure antagonist of GnRH stimulation of gonadotropin secretion; no agonistic actions of antide were manifest in vitro. Moreover, antide has no apparent noxious or toxic effect on pituitary cells in culture; the actions of antide are immediately reversible upon removal of antide from pituitary gonadotropes. We conclude that the long term inhibition of gonadotropin secretion by antide in vivo is not due to deleterious effects of this compound at the level of the pituitary gonadotrope.
Similar articles
-
Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation.Endocrinology. 1991 Apr;128(4):2041-4. doi: 10.1210/endo-128-4-2041. Endocrinology. 1991. PMID: 1900785
-
Effects of glucocorticoids on secretion of luteinizing hormone and follicle-stimulating hormone by female rat pituitary cells in vitro.Endocrinology. 1985 Sep;117(3):849-54. doi: 10.1210/endo-117-3-849. Endocrinology. 1985. PMID: 3926469
-
Effects of gonadectomy on the in vitro and in vivo gonadotropin responses to gonadotropin-releasing hormone in male and female rats.Endocrinology. 1989 Mar;124(3):1370-9. doi: 10.1210/endo-124-3-1370. Endocrinology. 1989. PMID: 2492928
-
Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland.Endocr Rev. 1999 Feb;20(1):46-67. doi: 10.1210/edrv.20.1.0355. Endocr Rev. 1999. PMID: 10047973 Review.
-
[Mechanism of action of gonadoliberin in pituitary gonadotropic cells].Ann Endocrinol (Paris). 1990;51(2):65-71. Ann Endocrinol (Paris). 1990. PMID: 2173467 Review. French.
Cited by
-
Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.J Clin Invest. 1994 Jun;93(6):2332-9. doi: 10.1172/JCI117238. J Clin Invest. 1994. PMID: 8200967 Free PMC article.
-
Early preclinical work with gonadotropin-releasing hormone analogues.F S Rep. 2023 Feb 4;4(2 Suppl):51-55. doi: 10.1016/j.xfre.2023.02.001. eCollection 2023 Jun. F S Rep. 2023. PMID: 37223770 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources